SCHEMBL25925927

SCHEMBL25925927

COc1ccc(O)c(/N=N/c2nc(SC)ns2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 12/20 0.43
MEN1 O00255 9/20 0.43
MAPT P10636 7/20 0.43
L3MBTL1 Q9Y468 6/20 0.43
MAPK1 P28482 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
POLB P06746 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
HTT P42858 2/20 0.43
RAB9A P51151 6/20 0.43
NPC1 O15118 6/20 0.43
KDM4E B2RXH2 3/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 3/20 0.38
RECQL P46063 2/20 0.38
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38
BLM P54132 1/20 0.38
MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925923 0.76 L3MBTL1 (0.35) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL25925913 0.76 MEN1 (0.50) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL25925876 0.76 KMT2A (0.33) KMT2AMEN1MAPK1POLBRAB9A
SCHEMBL24504697 0.75 KMT2A (0.49) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL24504568 0.74 PTGS2 (0.39) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL12795330 0.72 CYP1A2 (0.33) KMT2AMEN1L3MBTL1TSHRHSD17B10
SCHEMBL20280358 0.72 L3MBTL1 (0.68) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL11475446 0.72 L3MBTL1 (0.68) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL25926084 0.72 KCNH2 (0.48) KMT2AMEN1MAPTL3MBTL1MAPK1
SCHEMBL16802936 0.71 PTGS1 (0.43) KMT2AMEN1MAPTL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 KMT2A 1814/4885MEN1 67/4885MAPT 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.